ATOS - Atossa Genetics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue---1.758
Cost of Revenue---132.411
Gross Profit----130.653
Operating Expenses
Research Development4,209.9812,328.087770.4272,359.593
Selling General and Administrative7,224.2524,859.3696,479.19310,268.372
Non Recurring----
Others----
Total Operating Expenses11,434.2337,187.4567,249.6212,760.376
Operating Income or Loss-11,434.233-7,187.456-7,249.62-12,758.618
Income from Continuing Operations
Total Other Income/Expenses Net29.299-935.125880.7350.431
Earnings Before Interest and Taxes-11,434.233-7,187.456-7,249.62-12,758.618
Interest Expense----
Income Before Tax-11,404.934-8,122.581-6,368.885-12,758.187
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-11,404.934-8,122.581-6,368.885-12,758.187
Non-recurring Events
Discontinued Operations----3,002.136
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-11,404.934-8,122.581-6,368.885-15,760.323
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-22,884.242-10,690.713-6,368.885-15,760.323